Journal of Gastroenterology

Papers
(The median citation count of Journal of Gastroenterology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom179
Corynoline protects chronic pancreatitis via binding to PSMA2 and alleviating pancreatic fibrosis92
Ratio of submucosal thickness to total bowel wall thickness as a new sonographic parameter to estimate endoscopic remission of ulcerative colitis83
Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers79
Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease59
Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism58
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy54
Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts53
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma51
Managing radiation safety and protection in gastroenterology in Japan: insights from the REX-GI study50
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy47
Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: a retrospectiv46
Correlation between mismatch repair and survival of patients with gastric cancer after 5-FU-based adjuvant chemotherapy42
Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus38
Predictive factors for the progression of primary localized stage small-bowel follicular lymphoma38
Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan34
Associations between excessive supragastric belching and esophageal reflux factors in patients with PPI-refractory GERD in Japan31
Hic-5 deficiency attenuates MAFLD by inhibiting neutrophils migration via the CXCL1-CXCR2 axis30
Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database29
Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data29
The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery29
Clinical practice guidelines for duodenal cancer 202129
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy29
Novel subharmonic-aided pressure estimation for identifying high-risk esophagogastric varices28
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis28
Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial28
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials27
Successful induction of human chemically induced liver progenitors with small molecules from damaged liver27
Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation26
Persistent body-weight change on achalasia and peroral endoscopic myotomy: a multicenter cohort study26
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey25
Acknowledgements24
Correction: Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis24
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis23
Expert consensus on vaccination in patients with inflammatory bowel disease in Japan23
Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 202123
Evaluation of cholecystectomy in older individuals using real-world data: a multilevel analysis based on a nationwide administrative database in Japan23
Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study)23
Current status and trends in ERCP and post-ERCP pancreatitis in Japan: a nationwide observational study22
What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?22
A study for every second day administration of vonoprazan for maintenance treatment of erosive GERD (ESD von GERD): a multicenter randomized cross-over study21
Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan21
Is it necessary for endoscopic surveillance for achalasia patients?20
Nationwide cohort study identifies clinical outcomes of angioectasia in patients with acute hematochezia19
Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study19
Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinoma19
Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study19
Targeting autophagy as a therapeutic strategy against pancreatic cancer19
Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials19
Utility of artificial intelligence with deep learning of hematoxylin and eosin-stained whole slide images to predict lymph node metastasis in T1 colorectal cancer using endoscopically resected specime19
Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases18
Reply to “Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data”18
Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)18
“Pathologist-independent” strategy for T1 colorectal cancer after endoscopic resection18
RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer18
Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-1918
Cancer pathways in serrated polyposis syndrome: is conventional more crucial than serrated?17
Gastric cancer and genomics: review of literature17
VPS45 promotes the progression of hepatocellular carcinoma by recycling β1 integrin to the cell membrane via the endocytic pathway17
Reply to “promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy”16
Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL)16
Nationwide estimates of patient numbers and prevalence rates of ulcerative colitis and Crohn’s disease in Japan in 202316
Characteristics, outcomes, and risk factors of surgery for acute lower gastrointestinal bleeding: nationwide cohort study of 10,342 hematochezia cases16
Correction: Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multic16
Effect of blood product transfusion on the prognosis of patients undergoing hepatectomy for hepatocellular carcinoma: a propensity score matching analysis16
Identification of novel plasma proteins as promising noninvasive biomarker for early diagnosis and surveillance of pancreatic ductal adenocarcinoma15
Frequency of lymph node metastasis according to tumor location in clinical T1 early gastric cancer: supplementary analysis of the Japan Clinical Oncology Group study (JCOG0912)15
Molecular imaging of gastrointestinal stromal tumor using anti-c-KIT antibody and its fragments15
Impact of ursodeoxycholic acid treatment on Fontan-associated liver disease14
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation14
Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society14
AI-assisted diagnosis of Helicobacter pylori infection: strengths, limitations, and future directions14
The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry14
Risk of gastric and oesophageal adenocarcinomas following discontinuation of long-term proton-pump inhibitor therapy14
Efficacy, tolerability, and safety of oral sulfate tablet versus 2 L-polyethylene glycol/ascorbate for bowel preparation in older patients: prospective, multicenter, investigator single-blinded, rando13
Treatment strategy after noncurative endoscopic resection for early gastric cancers in patients aged ≥ 85 years: a multicenter retrospective study in a highly aged area of Japan13
The role of stromal BMP/CXCL12 signaling axis in serrated polyp development13
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data13
Correction: Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer13
The external validation of Dallas Steatosis Index among Asian population: a useful tool for metabolic dysfunction-associated steatotic liver disease identification and prevention13
Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearance13
Correction to: Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia13
Novel scale for evaluating the therapeutic efficacy of per-oral endoscopic myotomy in achalasia13
Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy12
Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY12
Validation of novel scoring systems for acute decompensated cirrhosis identifies PBC as an independent poor prognostic factor: a single-center Japanese cohort study12
Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation12
Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance12
Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis12
Prevalence of colonoscopy in Japan using a large-scale health claims data compared to esophagogastroduodenoscopy12
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study12
Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia11
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-co11
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis11
Renal manifestations in inflammatory bowel disease: a systematic review11
Definitive-dose adjuvant radiotherapy following endoscopic submucosal dissection for superficial esophageal cancer11
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma11
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer11
Correction: Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia11
Acknowledgements11
Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis11
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study11
Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease11
A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation11
Publisher Correction: Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study11
Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy10
Response to letter to the editor regarding: “Alcohol-associated liver disease increases the risk of muscle reduction and mortality in patients with cirrhosis”10
Metabolic dysfunction-associated steatotic liver disease affects the development of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients10
Reply to “Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19”9
Posttreatment serum CXCL10 level stratifies survival in compensated and decompensated cirrhotic patients due to chronic hepatitis C virus infection after direct-acting antiviral therapy9
Estimating cancer risk in immune-mediated inflammatory diseases exposed to varying doses of tumour necrosis factor inhibitors9
Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway9
Clarifying diagnostic scope and future perspectives in AI-assisted diagnosis of Helicobacter pylori infection9
Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection9
Letter to "The potential of an artificial intelligence for diagnosing MRI images in rectal cancer: multicenter collaborative trial"9
Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer9
The antiferroptotic effect of indigo on ulcerative colitis9
Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study9
Growing evidence on the highly sensitive iTACT assay of hepatitis B core-related antigen for predicting hepatitis B virus reactivation9
Acknowledgements9
FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma9
The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer9
Activating KRAS and GNAS mutations in heterotopic submucosal glands of the stomach9
Development of a capsule endoscopy scoring system for the early diagnosis of small bowel Crohn’s disease9
Current status of type 1 (IgG4-related) autoimmune pancreatitis9
LncRNA n339260 functions in hepatocellular carcinoma progression via regulation of miRNA30e-5p/TP53INP1 expression8
Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG05028
Profile of plasma microRNAs as a potential biomarker of Wilson’s disease8
Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis, 1990–2019: a decomposition and age–period–cohort analysis8
Cost–utility analysis of treatment strategies for chronic constipation in Japan8
Correction to: Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis8
Effects of luseogliflozin on suspected MASLD in patients with diabetes: a pooled meta-analysis of phase III clinical trials8
Correction: LAT1 expression influences Paneth cell number and tumor development in ApcMin/+ mice8
Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases8
Correction to: Clinical guidelines for primary sclerosing cholangitis 20178
Cost-effectiveness analysis of nivolumab plus chemotherapy vs chemotherapy for patients with unresectable advanced or metastatic HER2-negative gastric or gastroesophageal junction or esophageal adenoc8
Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis8
Correction: Current status and future perspective of linked color imaging for gastric cancer screening: a literature review8
Serum Mac2-binding protein glycosylated isomer (M2BPGi) as a prognostic biomarker in pancreatic ductal adenocarcinoma: iCAFs-derived M2BPGi drives tumor invasion8
An integrative multi-omics analysis reveals a multi-analyte signature of pancreatic ductal adenocarcinoma in serum8
Kindlin-2–miR-1258–TCF4 feedback loop promotes hepatocellular carcinoma invasion and metastasis8
Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study8
Serum FGF19 combined with GGT and other biomarkers predicted native liver survival following Kasai portoenterostomy in early biliary atresia8
Single-cell transcriptomics reveals hypoxia-driven iCAF_PLAU is associated with stemness and immunosuppression in anorectal malignant melanoma8
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus8
A novel artificial intelligence-based endoscopic ultrasonography diagnostic system for diagnosing the invasion depth of early gastric cancer8
Correction: Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCRES7
Long-term evaluation of Helicobacter pylori screening in school health checkups: an 11-year study in Japan7
Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis7
Impact of sarcopenia and changes in skeletal muscle mass on prognosis of patients with pancreatic ductal adenocarcinoma receiving chemotherapy with first-line gemcitabine and nab-paclitaxel: a prospec7
The useful predictors of zinc deficiency for the management of chronic liver disease7
Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR7
Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert review7
The magnetic resonance imaging and age-adjusted matrix metalloproteinase-7 assist the diagnosis of biliary atresia7
Dietary vitamin D intake and risk of colorectal cancer according to vitamin D receptor expression in tumors and their surrounding stroma7
The clinical outcome from early versus delayed minimally invasive intervention for infected pancreatic necrosis: a systematic review and meta-analysis7
Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multicenter random7
Impact of early aggressive treatment on long-term biochemical marker patterns in inflammatory bowel disease7
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis7
Educational interventions to enhance support for balancing work and treatment in inflammatory bowel disease patients7
Long-term risk of inflammatory bowel disease in patients with irritable bowel syndrome: the cross-sectional and longitudinal relationship7
Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases6
Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cells6
Acknowledgements6
Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study6
A survey questionnaire evaluating physical activity patterns and determinants in patients with chronic liver disease6
The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients6
Clinicopathological characteristics of colorectal serrated polyposis syndrome (SPS): results of a multicenter study by the SPS Study Group in Japan6
A clinicopathological study of IgG4-related autoimmune hepatitis and IgG4-hepatopathy6
Pancreatic atrophy and recovery after allogeneic hematopoietic cell transplantation6
Red dichromatic imaging and linked color imaging as reliable image-enhanced endoscopic procedures for detecting the distal end of the palisade vessels in the columnar metaplastic mucosa of the gastroe6
Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction6
The impact of the age-adjusted Charlson comorbidity index as a prognostic factor for endoscopic papillectomy in ampullary tumors6
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study6
Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization6
The interplay between alterations in esophageal microbiota associated with Th17 immune response and impaired LC20 phosphorylation in achalasia6
CACNA2D1 regulates the progression and influences the microenvironment of colon cancer6
The clonal heterogeneity of colon cancer with liver metastases6
Reply to ‘C-CAT's triumph in gastroenterology: the wisdom of cats is infinitely superior’6
Letrozole ameliorates liver fibrosis through the inhibition of the CTGF pathway and 17β-hydroxysteroid dehydrogenase 13 expression5
High-mobility group box 1: friend or foe in pancreatitis5
Determination of optimal cutoff value of ulcerative colitis intestinal ultrasound index to estimate endoscopic improvement in ulcerative colitis5
Autoantibodies against endothelial protein C receptor and integrin αvβ6 predict the development of ulcerative colitis5
iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study5
Real-world efficacy of antibiotic prophylaxis for upper gastrointestinal bleeding in cirrhotic patients in Japan5
Development of gastric mucosa-associated microbiota in autoimmune gastritis with neuroendocrine tumors5
Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan5
Importance of rectal over colon status in ulcerative colitis remission: the role of microinflammation and mucosal barrier dysfunction in relapse5
Nationwide survey for patients with acute-on-chronic liver failure occurring between 2017 and 2019 and diagnosed according to proposed Japanese criteria5
Hepatitis B core-related antigen kinetics predict spontaneous HBeAg seroclearance in chronic hepatitis B patients5
Efficacy and safety of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients with esophageal–gastric varices5
New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease5
Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria5
Effect of tumor microenvironment in pancreatic cancer on the loss of β-cell mass: implications for type 3c diabetes5
The 2024 diagnostic criteria for primary sclerosing cholangitis5
Development and validation of a claims-based algorithm to identify incidents and determine the progression phases of gastric cancer cases in Japan5
Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide™ NCC Oncopanel System analysis suitability criteria: a single-a5
Correction: The association between antigenemia, histology with immunohistochemistry, and mucosal PCR in the diagnosis of ulcerative colitis with concomitant human cytomegalovirus infection4
Does early intervention for infected pancreatic necrosis lead to better clinical outcomes compared to delayed intervention?4
Current status of waitlist mortality and transplant probability for adult candidates with chronic end-stage liver disease for deceased donor liver transplantation under the Model for End-Stage Liver D4
Thiopurines exert harmful effects on spermatogenesis in Nudt15R138C knock-in mice4
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort4
Resistant starch reduces glycolysis by HK2 and suppresses high-fructose corn syrup-induced colon tumorigenesis4
Postinfectious onset in functional dyspepsia is a risk factor for weight loss4
Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting4
Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicen4
Medium-chain and long-chain fatty acids are associated with diarrheal predominant irritable bowel syndrome revealed by DESI-MSI4
Factors associated with the development of bacterial pneumonia and the preventive potential of peroral endoscopic myotomy in patients with esophageal motility disorders: a case–control study4
Clinical features and endoscopic polyp management of Peutz–Jeghers syndrome: the 2nd nationwide epidemiological survey in Japan4
Validation of the Japanese version of the Esophageal Hypervigilance and Anxiety Scale for esophageal symptoms4
A combination of liver stiffness and international normalized ratio is an ideal prognostic predictor of portosystemic shunt occlusion in patients with portal hypertension4
First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control study4
Effect of gastric cancer screening on long-term survival of gastric cancer patients: results of Korean national cancer screening program4
Liver transplantation for gastroenteropancreatic neuroendocrine liver metastasis: optimal patient selection and perioperative management in the era of multimodal treatments4
Possibility of determining high quantitative fecal occult blood on stool surface using hyperspectral imaging4
Anti-integrin αvβ6 autoantibody in primary sclerosing cholangitis: a Japanese nationwide study4
Cox proportional hazards regression reveals more than a 100-fold difference in cancer risk by the length of Barrett’s esophagus in Japan4
Nuclear magnetic resonance-based metabolomics and risk of pancreatic cancer: a prospective analysis in the UK Biobank4
Comparative analysis of lenvatinib use after atezolizumab plus bevacizumab versus lenvatinib as first-line therapy in unresectable hepatocellular carcinoma3
Investigating tumor-infiltrating lymphocytes as predictors of lymph node metastasis in deep submucosal invasive esophageal squamous cell carcinoma: a retrospective cross-sectional study3
The role of sex hormones in the fecal microbiota of IBS-D patients with exacerbation of symptoms deserves attention3
Current status and future perspective of linked color imaging for gastric cancer screening: a literature review3
Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 20203
Group 1 innate lymphoid cells and inflammatory macrophages exacerbate fibrosis in creeping fat through IFN-γ secretion3
Neutrophil gelatinase-associated lipocalin predicts the efficacy of tolvaptan for ascites in patients with liver cirrhosis3
Comparing the predictive ability of portoatrial and portocaval gradient after transjugular intrahepatic portosystemic shunt creation for variceal rebleeding3
Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis3
Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection3
Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD3
Clinicopathologic differences of gastric neoplasms between Helicobacter pylori-infected and -naïve patients: a multicenter retrospective analysis3
Ferroptosis: biology and role in liver disease3
Controversy regarding the risk of autoimmune gastritis on gastric adenocarcinoma3
Age distribution and risk factors for Barrett's esophagus by sex at health check-up settings in Japan3
Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy3
Management of colorectal high-grade dysplasia or cancer resected by cold snare polypectomy: a multicenter exploratory study3
Smoking history and severe atrophic gastritis assessed by pepsinogen are risk factors for the prevalence of synchronous gastric cancers in patients with gastric endoscopic submucosal dissection: a mul3
Minocycline vs. tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial3
Mortality and cancer in eosinophilic gastrointestinal disorders distal to the esophagus: nationwide cohort study 1990–20173
Reply to “Ferroptosis in the colon epithelial cells as a therapeutic target for ulcerative colitis”3
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G23
Impact of preceding treatment for head and neck squamous cell carcinoma on synchronous superficial esophageal squamous cell carcinoma3
Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide survey3
A revolutionary oral HBV treatment candidate as innovative therapeutic approach warranting clinical trials3
A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma3
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy3
Inhibition of liver cancer cell growth by metabolites S-adenosylmethionine and nicotinic acid originating from liver progenitor cells3
Predictive factors for subsequent intrahepatic cholangiocarcinoma associated with hepatolithiasis: Japanese National Cohort Study for 18 years3
Identification of anti-Helicobacter pylori antibody signatures in gastric intestinal metaplasia3
Clinical impact of epithelial types on postoperative outcomes for intraductal papillary mucinous neoplasms: a multicenter retrospective study3
CircDCBLD2 alleviates liver fibrosis by regulating ferroptosis via facilitating STUB1-mediated PARK7 ubiquitination degradation3
0.24509811401367